SignalKorea

S. KOREA'S TOP PHARMACEUTICAL FIRMS SPEND OVER 100 BLN WON EACH IN H1 FOR R&D: DATA - YONHAP

R&D spending over 100 bln won each signals sector-wide innovation investment.

What changed

R&D spending over 100 bln won each signals sector-wide innovation investment.

Why it matters

R&D spending over 100 bln won each signals sector-wide innovation investment. — impact context not separately stored; see What changed.

Sources